Efficacy and Safety of Transjugular Intrahepatic Portosystemic Shunt in Difficult-to-manage Hydrothorax in Cirrhosis
Overview
Affiliations
Background: Pleural effusions (PE) complicate cirrhosis in ~5% of patients. Identification of cause and related complications is imperative. Unlike refractory ascites, large-scale studies on interventions for refractory PE are limited.
Methods: Consecutive hospitalized cirrhotics having PE were retrospectively analysed. None had liver transplantation (LT) within 6-month follow-up. We determined safety, efficacy and mortality predictors for PE managed with standard medical treatment (SMT), thoracentesis, catheter drainage and TIPS.
Results: Of 1149 cirrhotics with PE (mean Child-Pugh 10.6 ± 1.8 and MELD 21.2 ± 7.4), 82.6% had hepatic hydrothorax (HH) and 12.3% were suspected tubercular PE (TBPE). Despite comparable HVPG and MELD scores, patients with HH developed more AKI, encephalopathy and septic shock (all P < .01) on follow-up. Among HH, 73.5% were symptomatic, 53.2% isolated right-sided PE and 21.3% had SBE. Presence of SBP [Odd's ratio, OR: 4.5] and catheter drainage [OR: 2.1] were independent predictors for SBE. In 70.3% of admissions, HH responded to SMT alone, 12.9% required thoracentesis and 11.5% underwent catheter drainage. Fifty-one patients were selected for TIPS [lower mean CTP 9.9 ± 1.6 and MELD score 18.7 ± 5.4]. Despite reduction in pressure gradient from 23.1 ± 3.8 mm Hg to 7.2 ± 2.5 mm Hg, 25 patients had partial response, 10 had complete HH resolution. Major post-TIPS complications were portosystemic encephalopathy (eight patients, six resolved) and ischaemic hepatitis (four patients, two resolved). Overall, 35.9% patients with HH had 6-month mortality and independent predictors were MELD > 25, SBP and septic shock.
Conclusion: Refractory PE in cirrhosis requiring interventions including TIPS has poor outcome. The role of haemodynamics in predicting post-TIPS response and complications is limited. Early referral for LT is imperative.
Giri S, Patel R, Tripathy T, Chaudhary M, Anirvan P, Chauhan S Indian J Radiol Imaging. 2024; 34(4):670-676.
PMID: 39318562 PMC: 11419751. DOI: 10.1055/s-0044-1786828.
Pleural effusion due to nonmalignant gastrointestinal disease.
Ferreiro L, Casal A, Toubes M, Suarez-Antelo J, Golpe A, Abelleira-Paris R ERJ Open Res. 2023; 9(3).
PMID: 37143832 PMC: 10152270. DOI: 10.1183/23120541.00290-2022.
Ma B, Shang T, Huang J, Tu Z, Wang Y, Han Y Front Med (Lausanne). 2022; 9:904414.
PMID: 36148461 PMC: 9485448. DOI: 10.3389/fmed.2022.904414.
The challenges of ascites management: An Indian perspective.
Kulkarni A, Premkumar M, Reddy D, Rao P Clin Liver Dis (Hoboken). 2022; 19(6):234-238.
PMID: 35795622 PMC: 9248925. DOI: 10.1002/cld.1209.
Tellez L, Guerrero A Clin Drug Investig. 2022; 42(Suppl 1):15-23.
PMID: 35522396 PMC: 9205830. DOI: 10.1007/s40261-022-01149-3.